Different GLP-1 therapies could be tailored to patients individual metabolic needs A new analysis shows that GLP-1 therapies can deliver distinct benefits to different heart and metabolic health needs beyond just weight loss
The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nationwide prescription database
IGF-1 LR3 is engineered to do the same thing, but for a much longer period of time and without being captured by the proteins that normally limit IGF-1 activity
Tondt, J., Freshwater, M., Christensen, S., Iliakova, M., Weaver, E., Benson-Davies, S., Younglove, C., Afreen, S., Karjoo, S., Khan, N., Pennings, N., Thiara, D., & Whittle, C